Aghia Sophia Children's Hospital Athens Greece

Department of Haematology Great Ormond Street Hospital London UK

Department of Hematology and Stem Cell Transplantation University Hospital Essen Essen Germany

Department of Hematology Erasmus Medical Center Rotterdam Netherlands

Department of Paediatric Haematology and Oncology Hanover Germany

Fondazione GIMEMA Franco Mandelli onlus Rome Italy

Institute for Biomedical Research of Salamanca Salamanca Spain

UCL Cancer Institute London UK

University Hospital Brno Czechia

Wolfson Childhood Cancer Research Centre Translation and Clinical Research Institute Newcastle University Centre for Cancer Newcastle Upon Tyne UK

Zobrazit více v PubMed

Moorman AV, Ensor HM, Richards SM, Chilton L, Schwab C, Kinsey SE, et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol. 2010;11:429–38. doi: 10.1016/S1470-2045(10)70066-8. PubMed DOI

Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020;395:1146–62. doi: 10.1016/S0140-6736(19)33018-1. PubMed DOI

Paulsson K, Johansson B. High hyperdiploid childhood acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2009;48:637–60. doi: 10.1002/gcc.20671. PubMed DOI

Teachey DT, Pui CH. Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia. Lancet Oncol. 2019;20:e142–e54. doi: 10.1016/S1470-2045(19)30031-2. PubMed DOI PMC

Heerema NA, Sather HN, Sensel MG, Zhang T, Hutchinson RJ, Nachman JB, et al. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes) J Clin Oncol. 2000;18:1876–87. doi: 10.1200/JCO.2000.18.9.1876. PubMed DOI

Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N. Engl J Med. 2009;360:2730–41. doi: 10.1056/NEJMoa0900386. PubMed DOI PMC

Irving JA, Enshaei A, Parker CA, Sutton R, Kuiper RP, Erhorn A, et al. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia. Blood. 2016;128:911–22. doi: 10.1182/blood-2016-03-704973. PubMed DOI PMC

Enshaei A, Vora A, Harrison CJ, Moppett J, Moorman AV. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials. Lancet Haematol. 2021;8:e828–39. doi: 10.1016/S2352-3026(21)00304-5. PubMed DOI PMC

Moorman AV, Antony G, Wade R, Butler ER, Enshaei A, Harrison CJ, et al. Time to cure for childhood and young adult acute lymphoblastic leukemia is independent of early risk factors: long-term follow-up of the UKALL2003 Trial. J Clin Oncol. 2022;40:4228–39. doi: 10.1200/JCO.22.00245. PubMed DOI

Team RC. R: A language and environment for statistical computing. 2018.

O’Connor D, Enshaei A, Bartram J, Hancock J, Harrison CJ, Hough R, et al. Genotype-specific minimal residual disease interpretation improves stratification in pediatric acute lymphoblastic leukemia. J Clin Oncol. 2018;36:34–43. doi: 10.1200/JCO.2017.74.0449. PubMed DOI PMC

Haas OA, Borkhardt A. Hyperdiploidy: the longest known, most prevalent, and most enigmatic form of acute lymphoblastic leukemia in children. Leukemia. 2022;36:2769–83. doi: 10.1038/s41375-022-01720-z. PubMed DOI PMC